Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03723915
Title Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.